178 related articles for article (PubMed ID: 21422202)
21. Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.
Rodriguez-Gómez J; Pérez-Nadales E; Gutiérrez-Gutiérrez B; Machuca I; Martinez-Martinez L; Rivera F; Cano A; Castón JJ; Robles JC; de la Fuente C; Rodríguez-López F; Rodriguez-Baño J; Torre-Cisneros J;
J Infect; 2019 Sep; 79(3):245-252. PubMed ID: 31276705
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
[TBL] [Abstract][Full Text] [Related]
23. Management of KPC-producing Klebsiella pneumoniae infections.
Bassetti M; Giacobbe DR; Giamarellou H; Viscoli C; Daikos GL; Dimopoulos G; De Rosa FG; Giamarellos-Bourboulis EJ; Rossolini GM; Righi E; Karaiskos I; Tumbarello M; Nicolau DP; Viale PL; Poulakou G; ;
Clin Microbiol Infect; 2018 Feb; 24(2):133-144. PubMed ID: 28893689
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
[No Abstract] [Full Text] [Related]
25. Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
Lambelet P; Tascini C; Fortunato S; Stefanelli A; Simonetti F; Vettori C; Leonildi A; Menichetti F
New Microbiol; 2017 Jul; 40(3):161-164. PubMed ID: 28513809
[TBL] [Abstract][Full Text] [Related]
26. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.
Papadimitriou-Olivgeris M; Marangos M; Fligou F; Christofidou M; Sklavou C; Vamvakopoulou S; Anastassiou ED; Filos KS
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):169-73. PubMed ID: 23886789
[TBL] [Abstract][Full Text] [Related]
27. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
[TBL] [Abstract][Full Text] [Related]
28. Epidemic of Klebsiella pneumoniae ST11 clone coproducing KPC-2 and 16S rRNA methylase RmtB in a Chinese University Hospital.
Li JJ; Sheng ZK; Deng M; Bi S; Hu FS; Miao HF; Ji ZK; Sheng JF; Li LJ
BMC Infect Dis; 2012 Dec; 12():373. PubMed ID: 23259910
[TBL] [Abstract][Full Text] [Related]
29. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
Endimiani A; Hujer AM; Perez F; Bethel CR; Hujer KM; Kroeger J; Oethinger M; Paterson DL; Adams MD; Jacobs MR; Diekema DJ; Hall GS; Jenkins SG; Rice LB; Tenover FC; Bonomo RA
J Antimicrob Chemother; 2009 Mar; 63(3):427-37. PubMed ID: 19155227
[TBL] [Abstract][Full Text] [Related]
30. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and outcome of
Del Puente F; Giacobbe DR; Salsano A; Maraolo AE; Ong DSY; Yusuf E; Tutino S; Marchese A; Santini F; Viscoli C
J Chemother; 2019; 31(7-8):359-366. PubMed ID: 31701842
[No Abstract] [Full Text] [Related]
32. Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
De Rosa FG; Corcione S; Cavallo R; Di Perri G; Bassetti M
Future Microbiol; 2015; 10(2):283-94. PubMed ID: 25689539
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
[TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
[TBL] [Abstract][Full Text] [Related]
35. Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae.
Cojutti P; Sartor A; Righi E; Scarparo C; Bassetti M; Pea F
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760900
[TBL] [Abstract][Full Text] [Related]
36. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
[TBL] [Abstract][Full Text] [Related]
37. Association of Colistin-Resistant KPC Clonal Strains with Subsequent Infections and Colonization and Biofilm Production.
Ferreira ML; Araújo BF; Gonçalves IR; Royer S; Campos PA; Machado LG; Batistão DWF; Brito CS; Gontijo-Filho PP; Ribas RM
Microb Drug Resist; 2018 Dec; 24(10):1441-1449. PubMed ID: 29792779
[TBL] [Abstract][Full Text] [Related]
38. Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
Cojutti P; Sartor A; Bassetti M; Scarparo C; Pea F
J Glob Antimicrob Resist; 2018 Sep; 14():238-241. PubMed ID: 29775786
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
40. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.
Liang Y; Yin X; Zeng L; Chen S
BMC Infect Dis; 2017 May; 17(1):363. PubMed ID: 28535790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
